Valeant Pharmaceuticals International

Bookmark

Add to MyYahoo RSS

Valeant Pharmaceuticals International News

News on Valeant Pharmaceuticals International (Ticker: VRX) continually updated from thousands of sources around the net.

Yesterday | Freshnews

Allergan to Request California Federal Court Block Valeant and...

Allergan, Inc. announced today that it has asked the United States District Court for the Central District of California to set an expedited schedule for discovery and a motion for a preliminary injunction against Valeant Pharmaceuticals , Pershing Square Capital Management, L.P. , and its principal, William A. Ackman, for violations of the ... (more)

Comment?

Related Topix: Allergan, Biotech, Vicept Therapeutics, California, California Government, Valeant Pharmaceuticals International

Mon Aug 25, 2014

Brandon Sun

Valeant acquires dermatology portfolio and speciality products from Valeo

Valeant Pharmaceuticals International said Monday that it has acquired a dermatology portfolio of drugs and several speciality products from Valeo Pharma.

Comment?

Related Topix: Medicine, Dermatology, Biotech, Valeant Pharmaceuticals International, Allergan

Sat Aug 23, 2014

USA Today

Allergan reviews meeting requests in takeover bid

Allergan reviews meeting requests in takeover bid Valeant Pharmaceuticals seeks to replace most of the board of the Botox maker.

Comment?

Related Topix: Biotech, Valeant Pharmaceuticals International, Irvine, CA

Fri Aug 22, 2014

Silicon Alley Insider

Valeant, Ackman To Submit Allergan Special Meeting Request-CNBC

Valeant Pharmaceuticals International Inc and Pershing Square Capital Management will submit a request on Friday to Allergan Inc for a special shareholders meeting, sources told CNBC television.

Comment?

Related Topix: Allergan, Biotech, Valeant Pharmaceuticals International

Holtville Tribune

FTC Approves Final Order Preserving Competition in Markets for Acne Treatments

Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Valeant Pharmaceuticals International, Inc.'s proposed $475 million acquisition of Precision Dermatology, Inc. would likely be anticompetitive.

Comment?

Related Topix: Medicine, Acne Vulgaris, Health, Biotech, Valeant Pharmaceuticals International, Retin-A, Tretinoin (generic)

Tue Aug 19, 2014

West Australian

Allergan seeks deal with Salix to fend off Valeant - WSJ

Raleigh, North Carolina-based Salix makes products used to prevent or treat gastrointestinal disorders.

Comment?

Related Topix: Biotech, Valeant Pharmaceuticals International, Raleigh, NC

Mon Aug 18, 2014

Bloomberg

Canada Stocks Rise a 3rd Day as Tensions Ease in Ukraine, Iraq

Canadian stocks rose a third day, extending a two-week high, as global equities advanced after negotiators from Ukraine and Russia discussed a possible truce.

Comment?

Related Topix: Financial Markets, Biotech, Valeant Pharmaceuticals International, Allergan

BioSpace

Valeant Pharmaceuticals International Extends Offer To Acquire Allergan Inc.

Valeant Pharmaceuticals International, Inc. is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology and branded generics.

Comment?

Related Topix: Allergan, Biotech, Valeant Pharmaceuticals International, Vicept Therapeutics

Fri Aug 15, 2014

Sys-Con Media

Valeant Extends Offer To Acquire Allergan

Valeant Pharmaceuticals International, Inc. is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology and branded generics.

Comment?

Related Topix: Allergan, Biotech, Vicept Therapeutics, Valeant Pharmaceuticals International

BioSpace

SEC Investigating Valeant Pharmaceuticals International, Pershing...

U.S. securities regulators are looking at the hostile takeover bid made by billionaire investor William Ackman and Valeant Pharmaceuticals for Botox maker Allergan Inc, a person familiar with the matter said on Thursday.

Comment?

Related Topix: Biotech, Valeant Pharmaceuticals International, Securities and Exchange Commission, Corporate / Securities Law, Law, Allergan

Thu Aug 14, 2014

AmericanBankingNews.com

Investors Purchase High Volume of Put Options on Valeant Pharmaceuticals Intl

Valeant Pharmaceuticals Intl was the recipient of unusually large options trading on Thursday.

Comment?

Related Topix: Biotech, Valeant Pharmaceuticals International, Biovail, Medicine, Healthcare Industry

Wed Aug 13, 2014

BioSpace

Valeant Pharmaceuticals International Receives FTC Second Request Under

The information request was issued under notification requirements of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended .

Comment?

Related Topix: Biotech, Valeant Pharmaceuticals International, Allergan, Vicept Therapeutics

Tue Aug 12, 2014

Business Journal

Duke University sets fundraising record for second straight year

Donors to Duke University set another giving record this year, breaking the previous record that stood for only one year.

Comment?

Related Topix: Duke University, Biotech

Mon Aug 11, 2014

Medical News

Valeant receives request for additional information from FTC under Hart-Scott-Rodino

Valeant Pharmaceuticals International, Inc. announced that the Company has received a request for additional information from the Federal Trade Commission in connection with Valeant's proposed acquisition of Allergan, Inc. .

Comment?

Related Topix: Biotech, Valeant Pharmaceuticals International, Allergan, Health

Sat Aug 09, 2014

Seeking Alpha

Allergan Will Create More Value For Shareholders By Remaining Independent

The battle between Allergan Inc. and Valeant Pharmaceuticals International Inc. is continuing.

Comment?

Related Topix: Biotech, Allergan, Vicept Therapeutics, Valeant Pharmaceuticals International

AmericanBankingNews.com

Valeant Pharmaceuticals Intl Receives Average Recommendation of "Buy" from Analysts

Valeant Pharmaceuticals Intl has earned a consensus rating of "Buy" from the nineteen brokerages that are currently covering the stock, American Banking & Market News reports .

Comment?

Related Topix: Biotech, Valeant Pharmaceuticals International, Biovail, Medicine, Healthcare Industry

Fri Aug 08, 2014

MarketWatch

Allergan upgraded to outperform at Leerink

Leerink said the current hostile takeover battle for Allergan by Valeant Pharmaceuticals International Inc is having little if any impact on Allergan's business.

Comment?

Related Topix: Biotech, Valeant Pharmaceuticals International

Wed Aug 06, 2014

AmericanBankingNews.com

Valeant Pharmaceuticals Intl Stock Rating Lowered by Zacks

They currently have a $101.00 price target on the stock. Zacks 's price objective would indicate a potential downside of 8.20% from the company's current price.

Comment?

Related Topix: Biotech, Valeant Pharmaceuticals International, Biovail, Medicine, Healthcare Industry

Customer Interaction Solutions

Institutional Shareholder Services (ISS) Recommends Allergan...

LAVAL, Quebec and NEW YORK, Aug. 6, 2014 /CNW/ -- Valeant Pharmaceuticals International, Inc. and Pershing Square Capital Management, L.P. today commented on Institutional Shareholder Services' recommendation in support of Pershing Square's effort to call a special meeting of Allergan shareholders.

Comment?

Related Topix: Allergan, Biotech, Vicept Therapeutics, Canada, Valeant Pharmaceuticals International

Tue Aug 05, 2014

AmericanBankingNews.com

Valeant Pharmaceuticals Intl Given Average Rating of "Buy" by Brokerages

Shares of Valeant Pharmaceuticals Intl have received an average recommendation of "Buy" from the nineteen analysts that are presently covering the stock, AnalystRatings.Net reports .

Comment?

Related Topix: Biotech, Valeant Pharmaceuticals International, Biovail, Medicine, Healthcare Industry

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••